Unique susceptibility of a human lung carcinoid tumor cell line to infection with BK virus

Virus Research

Volumn 149, Issue 1, 2010, Pages 128-132

  Haley, Sheila A ^a   O'Hara, Bethany A ^a   Banerjee, Rahul ^a   Atwood, Walter J ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Carcinoid; Neuroendocrine tumor; Polyomavirus

Indexed keywords

LUCIFERASE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS T ANTIGEN; VIRUS V ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BINDING ASSAY; BK VIRUS; BRONCHUS CARCINOID; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; IMMUNOFLUORESCENCE TEST; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; VIRUS ATTACHMENT; VIRUS GENE; VIRUS INFECTION; VIRUS VIRULENCE;

ANTIGENS, VIRAL, TUMOR; BK VIRUS; CARCINOID TUMOR; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENES, REPORTER; HUMANS; JC VIRUS; LUCIFERASES; LUNG NEOPLASMS; SIMIAN VIRUS 40; VIRAL STRUCTURAL PROTEINS; VIRUS ATTACHMENT; VIRUS REPLICATION;

BK POLYOMAVIRUS; POLYOMAVIRUS;

EID: 77449115173     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.01.013     Document Type: Article

References (26)

1. Ahlman H., Dahlstrom A., Gronstad K., Tisell L.E., Oberg K., Zinner M.J., and Jaffe B.M. The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin. Ann. Surg. 201 1 (1985) 81-86
2. Atwood W.J., Wang L., Durham L.C., Amemiya K., Traub R.G., and Major E.O. Evaluation of the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial cells. J. Neurovirol. 1 1 (1995) 40-49
3. Berge T., and Linell F. Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathol. Microbiol. Scand. A 84 4 (1976) 322-330
4. Chen B.J., and Atwood W.J. Construction of a novel JCV/SV40 hybrid virus (JCSV) reveals a role for the JCV capsid in viral tropism. Virology 300 2 (2002) 282-290
5. Dugan A., Eash S., and Atwood W.J. An N-linked glycoprotein with alpha (2,3)-linked sialic acid is a receptor for BK virus. J. Virol. 79 (2005) 14442-14445
6. Dugan A.S., Gasparovic M.L., Tsomaia N., Mierke D.F., O'Hara B.A., Manley K., and Atwood W.J. Identification of amino acid residues in BK virus VP1 that are critical for viability and growth. J. Virol. 81 21 (2007) 11798-11808
7. Eash S., Querbes W., and Atwood W.J. Infection of Vero cells by BK virus is dependent on caveolae. J. Virol. 78 21 (2004) 11583-11590
8. Fonseca-Elphick G., Querbes W., Jordan J.A., Gee G.V., Eash S., Manley K., Dugan A., Stanifer M., Bhatnagar A., Kroeze W.K., Roth B.L., and Atwood W.J. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306 (2004) 1241-1420
9. Gardner S.D., Field A.M., Coleman D.V., and Hulme B. New human papovavirus (BK) isolated from urine after renal transplantation. Lancet i (1971) 1253-1257
10. Girardi A.J., Slotnick V.B., and Hilleman M.R. Search for virus in human malignancies. I. In vitro studies. Proc. Soc. Exp. Biol. Med. 110 (1962) 776-785
11. Godwin II J.D. Carcinoid tumors. An analysis of 2,837 cases. Cancer 36 2 (1975) 560-569
12. Liu C.K., and Atwood W.J. Propagation and assay of the JC virus. Methods Mol. Biol. 165 (2001) 9-17
13. Liu C.K., Wei G., and Atwood W.J. Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha 2-6 linked sialic acids. J. Virol. 72 (1998) 4643-4649
14. Modlin I.M., Kidd M., Latich I., Zikusoka M.N., and Shapiro M.D. Current status of gastrointestinal carcinoids. Gastroenterology 128 6 (2005) 1717-1751
15. Modlin I.M., and Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 79 4 (1997) 813-829
16. Moertel C.G., Sauer W.G., Dockerty M.B., and Baggenstoss A.H. Life history of the carcinoid tumor of the small intestine. Cancer 14 (1961) 901-912
17. Padgett B., ZuRhein G., Walker D., Echroade R., and Dessel B. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet I (1971) 1257-1260
18. Pinchot S.N., Holen K., Sippel R.S., and Chen H. Carcinoid tumors. Oncologist 13 12 (2008) 1255-1269
19. Quaedvlieg P.F., Visser O., Lamers C.B., Janssen-Heijen M.L., and Taal B.G. Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. Ann. Oncol. 12 9 (2001) 1295-1300
20. Raptis L., and Vultur A. Neoplastic transformation assays. Methods Mol. Biol. 165 (2001) 151-164
21. Sippel R.S., and Chen H. Carcinoid tumors. Surg. Oncol. Clin. N. Am. 15 3 (2006) 463-478
22. Stilling G.A., Zhang H., Ruebel K.H., Leontovich A.A., Jin L., Tanizaki Y., Zhang S., Erickson L.A., Hobday T., and Lloyd R.V. Characterization of the functional and growth properties of cell lines established from ileal and rectal carcinoid tumors. Endocr. Pathol. 18 4 (2007) 223-232
23. Sweet B., and Hilleman M. The vacuolating virus, SV40. Proc. Soc. Exp. Biol. Med. 105 (1960) 420
24. Wilde M.I., and Markham A. Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications. Drugs 52 5 (1996) 773-794
25. Wolf H. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists. Scand. J. Rheumatol. Suppl. 113 (2000) 37-45
26. Yao J.C., Hassan M., Phan A., Dagohoy C., Leary C., Mares J.E., Abdalla E.K., Fleming J.B., Vauthey J.N., Rashid A., and Evans D.B. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol. 26 18 (2008) 3063-3072